Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Peter Heisig
Observed names:
Heisig, P.,
Heisig, Peter,
Heisig, Peter:,
P Heisig,
P. Heisig,
PETER HEISIG
show all 6
Institution:
Universität Hamburg
Observed institutions:
University of Leeds,
University of Bonn,
Universität Hamburg,
University of Cambridge,
University of Applied Sciences Potsdam,
Max Planck Institute for Molecular Genetics,
Fraunhofer Institute for Production Systems and Design Technology,
University of Lübeck
show all 8
ORCID:
0000-0001-8720-6375
Observed ORCID:
0000-0001-8720-6375
OpenAlex ID:
A5053298802
EUCAST expert rules in antimicrobial susceptibility testing
2011
·
R. Leclercq
, R. Cantón
, et al.
·
Clinical Microbiology and Infection
·
685
Harmonisation of knowledge management – comparing 160 KM frameworks around the globe
2009
·
Peter Heisig
·
Journal of Knowledge Management
·
616
Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli
1996
·
P Heisig
·
Antimicrobial Agents and Chemotherapy
·
286
Impact of gyrA and parC Mutations on Quinolone Resistance, Doubling Time, and Supercoiling Degree of Escherichia coli
1999
·
Simone Bagel
, Volker Hüllen
, et al.
·
Antimicrobial Agents and Chemotherapy
·
218
Knowledge management and business performance: global experts’ views on future research needs
2016
·
Peter Heisig
, Olunifesi Adekunle Suraj
, et al.
·
Journal of Knowledge Management
·
184
The future of knowledge management: an international delphi study
2004
·
Wolfgang Scholl
, Christine König
, et al.
·
Journal of Knowledge Management
·
162
Prevalence of gyrA , gyrB , parC , and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season
2000
·
Mark E. Jones
, Daniel F. Sahm
, et al.
·
Antimicrobial Agents and Chemotherapy
·
158
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro
1994
·
P Heisig
, R Tschorny
·
Antimicrobial Agents and Chemotherapy
·
134
Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli
1993
·
P Heisig
, H Schedletzky
, et al.
·
Antimicrobial Agents and Chemotherapy
·
121
Commonality among Fluoroquinolone-Resistant Sequence Type ST131 Extraintestinal Escherichia coli Isolates from Humans and Companion Animals in Australia
2011
·
Joanne L. Platell
, Rowland N. Cobbold
, et al.
·
Antimicrobial Agents and Chemotherapy
·
116
High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes
1993
·
Peter Heisig
·
Journal of Antimicrobial Chemotherapy
·
103
Effects of Different Drying Processes on the Material Properties of Bacterial Cellulose Membranes
2006
·
C. Clasen
, B. Sultanova
, et al.
·
Macromolecular Symposia
·
92
Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfopristin, Gentamicin, and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureus Strains
1999
·
Mark E. Jones
, Maarten R. Visser
, et al.
·
Antimicrobial Agents and Chemotherapy
·
89
PDF
Mechanisms of quinolone resistance
1994
·
B. Wiedemann
, P. Heisig
·
Infection
·
84
Prominence of an O75 Clonal Group (Clonal Complex 14) among Non-ST131 Fluoroquinolone-Resistant Escherichia coli Causing Extraintestinal Infections in Humans and Dogs in Australia
2012
·
Joanne L. Platell
, Darren J. Trott
, et al.
·
Antimicrobial Agents and Chemotherapy
·
78
Resistance to Moxifloxacin in Toxigenic Clostridium difficile Isolates Is Associated with Mutations in gyrA
2001
·
Grit Ackermann
, Yajarayma J. Tang
, et al.
·
Antimicrobial Agents and Chemotherapy
·
77
Alcohols for Skin Antisepsis at Clinically Relevant Skin Sites
2009
·
Mirja Reichel
, Peter Heisig
, et al.
·
Antimicrobial Agents and Chemotherapy
·
74
Exploring knowledge and information needs in engineering from the past and for the future – results from a survey
2010
·
Peter Heisig
, Nicholas H.M. Caldwell
, et al.
·
Design Studies
·
70
Business Process Oriented Knowledge Management
2003
·
Peter Heisig
·
Springer eBooks
·
69
Uncomplicated Urinary Tract Infections and Antibiotic Resistance—Epidemiological and Mechanistic Aspects
2014
·
Bernd Wiedemann
, Anke Heisig
, et al.
·
Antibiotics
·
64
PDF
Type II topoisomerases--inhibitors, repair mechanisms and mutations
2009
·
P. Heisig
·
Mutagenesis
·
63
Identification of DNA Gyrase A Mutations in Ciprofloxacin-Resistant Isolates of Salmonella typhimurium from Men and Cattle in Germany
1995
·
P. Heisig
, B. Kratz
, et al.
·
Microbial Drug Resistance
·
55
Wissensbilanzen — Intellektuelles Kapital erfolgreich nutzen und entwickeln
2005
·
Kay Alwert
, Peter Heisig
, et al.
·
Springer eBooks
·
53
Knowledge Management
2003
·
Vorbeck, Jens
, Heisig, Peter
, et al.
·
Springer eBooks
·
52
Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance
2010
·
Nadine-C. Emrich
, Anke Heisig
, et al.
·
Journal of Antimicrobial Chemotherapy
·
49
Show more works
View as search
Works count:
141
Citation count:
5,158
H-index:
39
I10-index:
70
Year
Topic
Type
